Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
=======================================================================================================================================================================================

* Kathleen E. Fenerty
* Michelle Padget
* Benjamin Wolfson
* Sofia R. Gameiro
* Zhen Su
* John H. Lee
* Shahrooz Rabizadeh
* Patrick Soon-Shiong
* James W. Hodge